CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Menstrual Migraine
Interventions
DRUG

Treximet

Tablet for oral administration contains sumatriptan 85mg / naproxen sodium 500mg.

DRUG

Placebo

A placebo tablet matching Treximet for oral administration.

Trial Locations (2)

65807

Clinvest, Springfield

45267-0535

University Internal Medicine Associates, Inc., Cincinnati

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Cady, Roger, M.D.

INDIV

NCT01329562 - CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet | Biotech Hunter | Biotech Hunter